An Act relative to PANDAS/PANS screening in medical/clinical settings

Summary

The bill directs that patients in medical or clinical environments be screened for Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections (PANDAS) and Pediatric Acute‑onset Neuropsychiatric Syndrome (PANS). It would affect healthcare providers and patients by establishing screening practices to identify these conditions earlier, aiming to improve diagnosis and treatment.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share